Arkolith/Insider Trading/IMGO/Form 4

Rienhoff Hugh JR

Chief Executive Officer, DirectorImago BioSciences, Inc. (IMGO) · full profile →Form 4 · filed Jan 5, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 3, 2023Option exercise(M)7K$2.52$19K502K
Jan 3, 2023Option exercise(M)5K$2.52$12K494K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 3, 2023Option exercise(M)5K—$00
Jan 3, 2023Option exercise(M)7K—$00

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-23-000457) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML